Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

5 Most popular Pharmacovigilance blog posts of 2016

Posted on January 26th, 2017 by in Pharmacovigilance

Trends 2016

The most-read pharmacovigilance posts of the year really demonstrate the breadth and depth of issues that professionals in this area are dealing with. In these blogs, authors tackled subjects as varied as leadership needs, compliance metrics, the role of scientific literature in identifying adverse events, challenges presented by biosimilars, and the link between PV and other company programs.

  1. What do Pharmacovigilance and Market Research Programs have in common?

Posted on September 2nd, 2016 by J.-P. Clement MD in Pharmacovigilance


  1. Screening Scientific Literature for Adverse Drug Reactions: Relevant for Patient Safety or Just a Time-Consuming Regulatory Obligation?

Posted on November 16th, 2015 by Joyce de Langen in Pharmacovigilance


  1. Compliance Metrics for Pharmacovigilance Activities

Posted on August 19th, 2016 by J.-P. Clement MD in Pharmacovigilance


  1. The Changing Competencies of Pharmacovigilance Leadership

Posted on June 27th, 2016 by J.-P. Clement MD in Pharmacovigilance


  1. Biosimilars and Pharmacovigilance: 5 Key Challenges

Posted on April 7th, 2016 by Betsy Davis in Pharmacovigilance


All opinions shared in this post are the author’s own.

R&D Solutions for Pharma & Life Sciences

We're happy to discuss your needs and show you how Elsevier's Solution can help.

Contact Sales